1. Treating depression in patients with CVD: safe, effective approaches
- Author
-
Culpepper, Larry
- Subjects
Anxiety -- Risk factors ,Anxiety -- Diagnosis ,Anxiety -- Drug therapy ,Anxiety -- Research ,Anxiety -- Reports ,Anxiety -- Social aspects ,Anxiety -- Health aspects ,Blood sugar -- Reports ,Blood sugar -- Social aspects ,Blood sugar -- Health aspects ,Coronary heart disease -- Risk factors ,Coronary heart disease -- Diagnosis ,Coronary heart disease -- Drug therapy ,Coronary heart disease -- Research ,Coronary heart disease -- Reports ,Coronary heart disease -- Social aspects ,Coronary heart disease -- Health aspects ,Mental health -- Reports ,Mental health -- Social aspects ,Mental health -- Health aspects ,Isoenzymes -- Reports ,Isoenzymes -- Social aspects ,Isoenzymes -- Health aspects ,Comorbidity -- Risk factors ,Comorbidity -- Diagnosis ,Comorbidity -- Drug therapy ,Comorbidity -- Research ,Comorbidity -- Reports ,Comorbidity -- Social aspects ,Comorbidity -- Health aspects ,Cardiac patients -- Drug therapy ,Cardiac patients -- Sexual behavior ,Cardiac patients -- Reports ,Cardiac patients -- Social aspects ,Cardiac patients -- Health aspects ,Diabetes -- Risk factors ,Diabetes -- Diagnosis ,Diabetes -- Drug therapy ,Diabetes -- Research ,Diabetes -- Reports ,Diabetes -- Social aspects ,Diabetes -- Health aspects ,Cytochrome P-450 -- Reports ,Cytochrome P-450 -- Social aspects ,Cytochrome P-450 -- Health aspects ,Antidepressants, Tricyclic -- Research ,Antidepressants, Tricyclic -- Reports ,Antidepressants, Tricyclic -- Social aspects ,Antidepressants, Tricyclic -- Health aspects ,Physician and patient -- Reports ,Physician and patient -- Social aspects ,Physician and patient -- Health aspects ,Hypertension -- Risk factors ,Hypertension -- Diagnosis ,Hypertension -- Drug therapy ,Hypertension -- Research ,Hypertension -- Reports ,Hypertension -- Social aspects ,Hypertension -- Health aspects ,Congestive heart failure -- Risk factors ,Congestive heart failure -- Diagnosis ,Congestive heart failure -- Drug therapy ,Congestive heart failure -- Research ,Congestive heart failure -- Reports ,Congestive heart failure -- Social aspects ,Congestive heart failure -- Health aspects ,Arrhythmia -- Risk factors ,Arrhythmia -- Diagnosis ,Arrhythmia -- Drug therapy ,Arrhythmia -- Research ,Arrhythmia -- Reports ,Arrhythmia -- Social aspects ,Arrhythmia -- Health aspects ,Isosorbide mononitrate -- Reports ,Isosorbide mononitrate -- Social aspects ,Isosorbide mononitrate -- Health aspects ,Medical research -- Reports ,Medical research -- Social aspects ,Medical research -- Health aspects ,Medicine, Experimental -- Reports ,Medicine, Experimental -- Social aspects ,Medicine, Experimental -- Health aspects ,Decision-making -- Reports ,Decision-making -- Social aspects ,Decision-making -- Health aspects ,Liver diseases -- Risk factors ,Liver diseases -- Diagnosis ,Liver diseases -- Drug therapy ,Liver diseases -- Research ,Liver diseases -- Reports ,Liver diseases -- Social aspects ,Liver diseases -- Health aspects ,Family medicine -- Reports ,Family medicine -- Social aspects ,Family medicine -- Health aspects ,Atherosclerosis -- Risk factors ,Atherosclerosis -- Diagnosis ,Atherosclerosis -- Drug therapy ,Atherosclerosis -- Research ,Atherosclerosis -- Reports ,Atherosclerosis -- Social aspects ,Atherosclerosis -- Health aspects ,Nitrates -- Reports ,Nitrates -- Social aspects ,Nitrates -- Health aspects ,Paroxetine -- Research ,Paroxetine -- Reports ,Paroxetine -- Social aspects ,Paroxetine -- Health aspects ,Fluoxetine -- Research ,Fluoxetine -- Reports ,Fluoxetine -- Social aspects ,Fluoxetine -- Health aspects ,Diseases -- Risk factors ,Diseases -- Diagnosis ,Diseases -- Drug therapy ,Diseases -- Research ,Diseases -- Reports ,Diseases -- Social aspects ,Diseases -- Health aspects ,Medicine -- Practice ,Medicine -- Reports ,Medicine -- Social aspects ,Medicine -- Health aspects ,Health - Published
- 2003